Leo Wealth LLC Cuts Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Leo Wealth LLC lessened its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 9.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,398 shares of the financial services provider’s stock after selling 249 shares during the quarter. Leo Wealth LLC’s holdings in iShares Biotechnology ETF were worth $349,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in IBB. Blue Fin Capital Inc. raised its holdings in iShares Biotechnology ETF by 0.7% in the 2nd quarter. Blue Fin Capital Inc. now owns 10,516 shares of the financial services provider’s stock valued at $1,443,000 after acquiring an additional 74 shares during the last quarter. Security National Bank of SO Dak lifted its position in iShares Biotechnology ETF by 0.7% during the second quarter. Security National Bank of SO Dak now owns 10,461 shares of the financial services provider’s stock worth $1,436,000 after buying an additional 75 shares during the period. SPC Financial Inc. lifted its position in iShares Biotechnology ETF by 2.4% during the third quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock worth $475,000 after buying an additional 75 shares during the period. Werba Rubin Papier Wealth Management boosted its stake in iShares Biotechnology ETF by 2.7% in the 3rd quarter. Werba Rubin Papier Wealth Management now owns 2,918 shares of the financial services provider’s stock worth $425,000 after buying an additional 76 shares during the last quarter. Finally, Main Street Financial Solutions LLC grew its holdings in iShares Biotechnology ETF by 1.0% in the 2nd quarter. Main Street Financial Solutions LLC now owns 8,002 shares of the financial services provider’s stock valued at $1,098,000 after buying an additional 82 shares during the period. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Trading Up 0.0 %

Shares of IBB stock opened at $144.00 on Wednesday. The firm’s 50-day simple moving average is $145.70 and its 200-day simple moving average is $139.90. iShares Biotechnology ETF has a 1-year low of $111.83 and a 1-year high of $150.57.

iShares Biotechnology ETF Dividend Announcement

The business also recently declared a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were issued a $0.2005 dividend. The ex-dividend date was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.